Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali
Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali
Active, not recruiting · NCT03909737 · Registry updated 2026-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali | Death, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Infant Death, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, pregnancy disorder, pregnancy disorder with abortive outcome | Active, not recruiting | Phase 4 | 2026-08-07 | NCT03909737 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bill and Melinda Gates Foundation | 67 |
| University of Maryland, Baltimore | 198 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre pour le Developpement des Vaccins - Mali | Bamako | Mali | 1 |